He has an excellent track record of tackling complex issues and implementing practical solutions, which will be important for our fast moving entrepreneurial company. He will be a great complement to the TrialStat leadership team.
Past News ReleasesRSS
Ottawa, ON (PRWEB) April 3, 2007
TrialStat Corporation (http://www.trialstat.com), a clinical data management on demand company, today named Peter Hunter to the position of Chief Financial Officer and Chief Operating Officer. Mr. Hunter brings more than 20-years of experience in corporate finance, corporate governance, strategic negotiations and general management. Prior to TrialStat, Mr. Hunter managed an independent consulting practice specializing in business financings, mergers and acquisitions and licensing agreements. His TrialStat responsibilities will include finance, accounting and operations. Mr. Hunter will help TrialStat to continue to build on its current growth in North American and European markets.
“Peter has a strong financial and management background that will help us to effectively manage the fundamentals of our business during this period of rapid expansion,” said Jonathan Barker, President and CEO, TrialStat. “He has an excellent track record of tackling complex issues and implementing practical solutions, which will be important for our fast moving entrepreneurial company. He will be a great complement to the TrialStat leadership team.”
Along with corporate financial management experience, Mr. Hunter has held Chief Executive Officer positions at the Sterling Group, a real estate and venture capital firm, and at the Enterprise Venture Capital Fund, where he was its founder. Mr. Hunter has a Bachelor of Commerce from the University of Ottawa and is a Certified Accountant.
“It’s exciting to be part of a company that offers customers a unique and powerful on demand electronic data capture solution using ClinicalAnalytics,” said Mr. Hunter. “TrialStat is hitting North American and European markets full stride and I’m looking forward to contributing to the growth of this company.”
ClinicalAnalytics (CA) 4.0, TrialStat’s on demand EDC solution, delivers speed, performance and a host of industry-leading capabilities to give customers the power and flexibility they need to get their clinical trials started quickly and cost effectively. CA 4.0 integrates the web and flexible data capture technologies, including image-based forms and handheld devices. It is the first EDC platform to allow all aspects of the study to be configured, deployed and managed through a browser-based interface, which enables customers to deploy studies in a matter of days.
TrialStat Corporation is a privately held company that delivers clinical data management on demand by combining the company’s software as a service products for electronic data capture and systematic reviews with its full suite of data management services. CA 4.0 is a robust and scaleable clinical EDC on demand solution used by leading academic and contract research organizations. SRS 4.0™ automates systematic reviews using real-time collaboration and management tools to achieve transparent, auditable and reproducible results quickly and cost-effectively. For more information, please visit us at http://www.trialstat.com.
ClinicalAnalytics 4.0 and SRS 4.0 are registered trademarks of TrialStat Corporation.
For media inquiries, please contact:
613-741-9909 ext 155
# # #